Panchsheel Organics Ltd (PANCHSHEEL) — shareholding pattern, promoter holding, financials and share price
About Panchsheel Organics Ltd (PANCHSHEEL)
Panchsheel Organics Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as PANCHSHEEL and on the BSE under scrip code 531726. Its ISIN is INE316G01019.
Incorporated in 1990, Panchsheel Organics Ltd is a manufacturer of Bulk Drug and Intermediate [1]
Panchsheel Organics is a manufacturer and exporter of Active Pharma Ingredients (APIs), intermediates, and finished formulations for human and veterinary use, boasting over 30 years of industry experience.
The company operates a multipurpose manufacturing unit in Indore, equipped with modern facilities spread across four manufacturing blocks. This enhances its capability to handle large orders and complex reactions.
Listed peers in Pharmaceuticals: Accretion Pharmaceuticals Ltd, Parnax Lab Ltd, Bio Medica Laboratories Ltd, Speciality Medicines Ltd, Auro Laboratories Ltd, Quest Laboratories Ltd.
Valuation & Returns
10 Jul 2026At ₹122.4 a share on 10 Jul 2026, Panchsheel Organics Ltd (PANCHSHEEL) was valued at a price-to-earnings ratio of 14.87x against an industry P/E of 36.41x and a price-to-book of 1.2x on a book value of ₹101.63 per share as of Mar 2025. Solomo computes return on equity of 8.1% and return on capital employed of 10.58% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 14.87x
- Industry P/E
- 36.41x
- P/B
- 1.2x
- EPS (TTM)
- ₹8.23
- Book value / share
- ₹101.63
- ROE
- 8.1%
- ROCE
- 10.58%
- ROA
- 6.64%
- Debt / equity
- 0.04x
- Dividend yield
- 2.61%
- EBITDA margin
- 16.01%
- 52-week range
- ₹86.1 – ₹184
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Panchsheel Organics Ltd (PANCHSHEEL) reported revenue of ₹107 crore, net profit of ₹11 crore and earnings per share of ₹8.22. That compares with revenue of ₹107 crore and net profit of ₹14 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹31.07 crore and net profit ₹1.7 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 69 | 103 | 105 | 107 | 107 |
| Net profit (₹ cr) | 8 | 14 | 14 | 14 | 11 |
| EPS (₹) | 8.33 | 11.94 | 10.71 | 10.47 | 8.22 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 11.14% | 16.24% | 15.79% | 1.86% |
| Profit growth | 18.30% | 21.13% | 18.18% | -2.27% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 56.12% of Panchsheel Organics Ltd (PANCHSHEEL) (unchanged from the previous quarter). Market capitalisation was ₹161 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: HUF 3.12%, DHEERAJ KUMAR LOHIA 2.17%, MICHAEL DSOUZA 2.02%, INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS 1.26%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 56.12% | - | - | - | 43.88% |
| Mar 2026 | 56.12% | - | - | - | 43.88% |
| Dec 2025 | 56.12% | - | - | - | 43.88% |
| Sep 2025 | 56.12% | - | - | - | 43.88% |
| Jun 2025 | 56.12% | - | - | - | 43.88% |
| Mar 2025 | 56.12% | - | - | 0.98% | 43.88% |
| Dec 2024 | 56.12% | - | - | 1.14% | 43.88% |
| Sep 2024 | 56.12% | - | - | 1.14% | 43.88% |